pharmaphorum July 10, 2025
Toymaker Mattel has launched its latest addition to the Barbie range of dolls, the first with type 1 diabetes, which comes complete with a wearable continuous glucose monitor (CGM) and insulin pump.
The new doll launches with one-off versions celebrating two type 1 diabetes (T1D) advocates – fitness instructor Robin Arzón in the US and model Lila Moss in the UK – and was developed in collaboration with patient advocacy group Breakthrough T1D.
Mattel has a strong heritage in bringing variants of its iconic doll to foster inclusivity, with a range of races and ethnicities represented, along with deaf, blind, and Down syndrome versions.
The regular version wears a blue polka dot top and matching skirt – the colour is...
Today's Sponsors
Today's Sponsor